vs

Side-by-side financial comparison of BLACK HILLS CORP (BKH) and Charles River Laboratories (CRL). Click either name above to swap in a different company.

Charles River Laboratories is the larger business by last-quarter revenue ($995.8M vs $241.6M, roughly 4.1× BLACK HILLS CORP). BLACK HILLS CORP runs the higher net margin — 55.1% vs -1.5%, a 56.6% gap on every dollar of revenue. On growth, Charles River Laboratories posted the faster year-over-year revenue change (1.2% vs -3.0%). Over the past eight quarters, Charles River Laboratories's revenue compounded faster (-1.5% CAGR vs -22.0%).

Black Hills Corporation is an American diversified energy company that is an electric and gas utility in South Dakota, Montana, Wyoming, Colorado, Arkansas, Kansas, Nebraska, and Iowa. The company sells power throughout the American West. The company is based in Rapid City, South Dakota. It derives its name from its home in the Black Hills of South Dakota.

Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation (CRO) headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices.

BKH vs CRL — Head-to-Head

Bigger by revenue
CRL
CRL
4.1× larger
CRL
$995.8M
$241.6M
BKH
Growing faster (revenue YoY)
CRL
CRL
+4.2% gap
CRL
1.2%
-3.0%
BKH
Higher net margin
BKH
BKH
56.6% more per $
BKH
55.1%
-1.5%
CRL
Faster 2-yr revenue CAGR
CRL
CRL
Annualised
CRL
-1.5%
-22.0%
BKH

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
BKH
BKH
CRL
CRL
Revenue
$241.6M
$995.8M
Net Profit
$133.1M
$-14.8M
Gross Margin
Operating Margin
83.6%
12.0%
Net Margin
55.1%
-1.5%
Revenue YoY
-3.0%
1.2%
Net Profit YoY
-2.4%
-157.2%
EPS (diluted)
$1.73
$-0.30

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BKH
BKH
CRL
CRL
Q1 26
$241.6M
$995.8M
Q4 25
$622.7M
$994.2M
Q3 25
$427.4M
$1.0B
Q2 25
$435.7M
$1.0B
Q1 25
$800.4M
$984.2M
Q4 24
$585.1M
$1.0B
Q3 24
$398.6M
$1.0B
Q2 24
$397.1M
$1.0B
Net Profit
BKH
BKH
CRL
CRL
Q1 26
$133.1M
$-14.8M
Q4 25
$104.9M
$-276.6M
Q3 25
$24.9M
$54.4M
Q2 25
$27.5M
$52.3M
Q1 25
$134.3M
$25.5M
Q4 24
$98.0M
$-214.5M
Q3 24
$24.4M
$69.7M
Q2 24
$22.8M
$94.1M
Gross Margin
BKH
BKH
CRL
CRL
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
34.6%
Q2 24
34.5%
Operating Margin
BKH
BKH
CRL
CRL
Q1 26
83.6%
12.0%
Q4 25
27.5%
-28.5%
Q3 25
18.4%
13.3%
Q2 25
18.9%
9.7%
Q1 25
25.6%
7.6%
Q4 24
27.9%
-16.7%
Q3 24
19.0%
11.6%
Q2 24
17.8%
14.8%
Net Margin
BKH
BKH
CRL
CRL
Q1 26
55.1%
-1.5%
Q4 25
16.8%
-27.8%
Q3 25
5.8%
5.4%
Q2 25
6.3%
5.1%
Q1 25
16.8%
2.6%
Q4 24
16.7%
-21.4%
Q3 24
6.1%
6.9%
Q2 24
5.7%
9.2%
EPS (diluted)
BKH
BKH
CRL
CRL
Q1 26
$1.73
$-0.30
Q4 25
$1.39
$-5.57
Q3 25
$0.34
$1.10
Q2 25
$0.38
$1.06
Q1 25
$1.87
$0.50
Q4 24
$1.36
$-4.17
Q3 24
$0.35
$1.33
Q2 24
$0.33
$1.74

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BKH
BKH
CRL
CRL
Cash + ST InvestmentsLiquidity on hand
$191.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.9B
Total Assets
$7.7B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BKH
BKH
CRL
CRL
Q1 26
$191.8M
Q4 25
$182.8M
$213.8M
Q3 25
$21.1M
$207.1M
Q2 25
$8.1M
$182.8M
Q1 25
$6.6M
$229.4M
Q4 24
$16.1M
$194.6M
Q3 24
$12.5M
$210.2M
Q2 24
$624.8M
$179.2M
Total Debt
BKH
BKH
CRL
CRL
Q1 26
Q4 25
$2.1B
Q3 25
$2.2B
Q2 25
$2.3B
Q1 25
$2.5B
Q4 24
$2.2B
Q3 24
$2.3B
Q2 24
$2.4B
Stockholders' Equity
BKH
BKH
CRL
CRL
Q1 26
$2.9B
Q4 25
$3.8B
$3.2B
Q3 25
$3.8B
$3.4B
Q2 25
$3.6B
$3.4B
Q1 25
$3.6B
$3.2B
Q4 24
$3.5B
$3.5B
Q3 24
$3.4B
$3.8B
Q2 24
$3.4B
$3.7B
Total Assets
BKH
BKH
CRL
CRL
Q1 26
$7.7B
Q4 25
$10.9B
$7.1B
Q3 25
$10.3B
$7.5B
Q2 25
$10.1B
$7.6B
Q1 25
$10.1B
$7.6B
Q4 24
$10.0B
$7.5B
Q3 24
$9.7B
$8.0B
Q2 24
$10.2B
$7.9B
Debt / Equity
BKH
BKH
CRL
CRL
Q1 26
Q4 25
0.68×
Q3 25
0.64×
Q2 25
0.70×
Q1 25
0.79×
Q4 24
0.65×
Q3 24
0.62×
Q2 24
0.65×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BKH
BKH
CRL
CRL
Operating Cash FlowLast quarter
$41.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
5.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BKH
BKH
CRL
CRL
Q1 26
$41.1M
Q4 25
$168.1M
$147.5M
Q3 25
$88.9M
$213.8M
Q2 25
$188.6M
$204.6M
Q1 25
$227.8M
$171.7M
Q4 24
$153.2M
$159.4M
Q3 24
$102.1M
$251.8M
Q2 24
$230.6M
$193.5M
Free Cash Flow
BKH
BKH
CRL
CRL
Q1 26
Q4 25
$-101.5M
$58.6M
Q3 25
$-89.5M
$178.2M
Q2 25
$-30.3M
$169.3M
Q1 25
$74.9M
$112.4M
Q4 24
$-60.5M
$83.7M
Q3 24
$-86.0M
$213.1M
Q2 24
$64.4M
$154.0M
FCF Margin
BKH
BKH
CRL
CRL
Q1 26
Q4 25
-16.3%
5.9%
Q3 25
-20.9%
17.7%
Q2 25
-7.0%
16.4%
Q1 25
9.4%
11.4%
Q4 24
-10.3%
8.4%
Q3 24
-21.6%
21.1%
Q2 24
16.2%
15.0%
Capex Intensity
BKH
BKH
CRL
CRL
Q1 26
5.6%
Q4 25
43.3%
8.9%
Q3 25
41.7%
3.5%
Q2 25
50.2%
3.4%
Q1 25
19.1%
6.0%
Q4 24
36.5%
7.5%
Q3 24
47.2%
3.8%
Q2 24
41.9%
3.8%
Cash Conversion
BKH
BKH
CRL
CRL
Q1 26
Q4 25
1.60×
Q3 25
3.57×
3.93×
Q2 25
6.86×
3.91×
Q1 25
1.70×
6.74×
Q4 24
1.56×
Q3 24
4.18×
3.61×
Q2 24
10.11×
2.06×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BKH
BKH

Segment breakdown not available.

CRL
CRL

Service revenue$798.2M80%
Product revenue$197.7M20%

Related Comparisons